about
Purinergic signaling in inflammatory renal diseaseIn vivo killing of Staphylococcus aureus using a light-activated antimicrobial agentOral hygiene care for critically ill patients to prevent ventilator associated pneumoniaMedication errors: a prospective cohort study of hand-written and computerised physician order entry in the intensive care unit.Treating critical illness: the importance of first doing no harmThe Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)Microcirculatory dysfunction and resuscitation: why, when, and howTissue oxygen tension monitoring of organ perfusion: rationale, methodologies, and literature reviewBiomarkers in sepsisClinical review: Update on hemodynamic monitoring--a consensus of 16Clinical review: Thinking outside the box--an iconoclastic view of current practiceLiver dysfunction and phosphatidylinositol-3-kinase signalling in early sepsis: experimental studies in rodent models of peritonitisThe effects of etomidate on adrenal responsiveness and mortality in patients with septic shockHydrocortisone therapy for patients with septic shockRecommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care MedicinePreliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unitTrial of Early, Goal-Directed Resuscitation for Septic ShockOur favorite unproven ideas for future critical care.Why aren't we practising homogenized medicine?Sequential Analysis of a Panel of Biomarkers and Pathologic Findings in a Resuscitated Rat Model of Sepsis and Recovery.Early, Goal-Directed Therapy for Septic Shock - A Patient-Level Meta-Analysis.Key bioactive reaction products of the NO/H2S interaction are S/N-hybrid species, polysulfides, and nitroxyl.Randomised controlled trial assessing the impact of a nurse delivered, flow monitored protocol for optimisation of circulatory status after cardiac surgery.Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression.Tissue oxygen and hemodynamics in renal medulla, cortex, and corticomedullary junction during hemorrhage-reperfusion.Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).Management of a mixed overdose of calcium channel blockers, β-blockers and statins.Changes in dental plaque following hospitalisation in a critical care unit: an observational study.An efficacy and mechanism evaluation study of Levosimendan for the Prevention of Acute oRgan Dysfunction in Sepsis (LeoPARDS): protocol for a randomized controlled trial.Inflammation biomarkers and delirium in critically ill patients.Oxygen consumption is depressed in patients with lactic acidosis due to biguanide intoxication.Ammonium tetrathiomolybdate following ischemia/reperfusion injury: Chemistry, pharmacology, and impact of a new class of sulfide donor in preclinical injury models.A plea for balanced reporting.Thirty years of critical care medicine.Changes in CRH and ACTH synthesis during experimental and human septic shockPeripheral neural detection of danger-associated and pathogen-associated molecular patternsSurvival in critical illness is associated with early activation of mitochondrial biogenesis.Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology.In vitro susceptibility of Gram-positive pathogens to linezolid and teicoplanin and effect on outcome in critically ill patients.
P50
Q21090463-E3976301-C53D-490A-9B62-05662E5A9869Q21263042-488FA1AE-A8BF-4261-935B-B9A8FD1A4C87Q24240212-F6C55DA8-DA9D-4DEF-A105-E58C405ECCD6Q24813401-FB6D7D9B-04F0-4D29-B06B-1D0E76F1D7CDQ24813804-39B225FC-3F05-456A-A9FA-8C3D31788026Q26768286-E4623ABE-B7ED-4F31-AEFF-08A48DE5A864Q26768292-E16F83E1-FD15-4D23-A8E7-7EE5B5CAA9B8Q26798312-F9157CF3-EFB4-4898-B534-DFE6659A648AQ26801225-47D1A29E-E08E-4852-B0A7-640B64987EA1Q26821873-73108930-246E-43EF-9390-D241E369856BQ26849387-23513AB2-4923-45E2-9B9D-360A218C39B3Q26865095-44D7A379-C541-4DFA-B02E-470047D0171DQ27307089-F2CFA992-1585-4662-A0C0-CFEBDD29D80FQ28253821-D9790BF0-6182-44C7-AF4A-F12849114795Q28264225-2EF8BFA1-CA98-4501-B1CB-BE31A001DB0DQ28280888-94F47ECA-C603-43F8-AB8A-062CABC4CEBDQ28377548-A1E1BE64-7796-4A79-B77E-AACB9EAB4644Q30053759-4E456F48-D776-4482-8A43-E20FB7BFF233Q30441767-00D4CE19-8D1D-408D-B8FA-E1B844CEDC06Q30483546-A2CD5408-513A-48B2-95C8-8E1D20ACEADAQ30491476-BA3EDD92-597C-409E-A565-E2491939D614Q30572421-162EE080-D911-4AA2-8997-59D48DB16E0BQ30662956-409CD22C-7D6D-4959-BE94-9D0F91FF25BAQ31090070-DD1D1E50-6776-4046-8B3D-D492F0212DC4Q31157664-1D1E9883-F6DE-450B-B43C-51B02764C11DQ33235843-7E461C97-7453-41BC-893C-7A0B6859DAB9Q33692899-73EED049-61B3-4B50-BCD3-7DB1698F2F06Q33743700-4B295EA5-12DE-48EF-8D9F-7052BF60ADD5Q33749855-8BCD4766-2814-48CF-97E7-125F0E190CAAQ33770902-0125CEB7-E2F6-4B3B-BCF4-CD6AD6CF458FQ33821403-26E2CE8F-9EF5-4762-BD8A-B425B1E1DC4FQ33873484-A09BC00B-101E-4C96-A464-A06A408828E1Q33873758-F3BAE3A5-F860-4190-ABB8-A1BC811539EFQ33919171-3DA45C1E-015E-4797-918C-B2178B274D30Q34026781-97383C06-2711-490C-B3A8-CC09AC7E8C8CQ34071510-9A70FC66-A7E0-48B1-9B32-07590E22CB31Q34134590-95944E92-88FA-423E-8AF9-2DB95DF83F4BQ34172119-04C27BE8-7EFD-4967-BFE0-F76EDE122B90Q34389554-1AAEE2F0-3967-4185-A4B8-8BAB268DB8E4Q34532009-F40B0397-FC1A-47E6-8BAB-A27708938CE1
P50
description
onderzoeker
@nl
physician; intensive care consultant
@en
name
Mervyn Singer
@ast
Mervyn Singer
@en
Mervyn Singer
@es
Mervyn Singer
@fr
Mervyn Singer
@nl
Mervyn Singer
@sl
type
label
Mervyn Singer
@ast
Mervyn Singer
@en
Mervyn Singer
@es
Mervyn Singer
@fr
Mervyn Singer
@nl
Mervyn Singer
@sl
prefLabel
Mervyn Singer
@ast
Mervyn Singer
@en
Mervyn Singer
@es
Mervyn Singer
@fr
Mervyn Singer
@nl
Mervyn Singer
@sl
P1006
P214
P244
P1006
P1053
J-4425-2012
P106
P21
P213
0000 0000 3522 0637
P214
P244
P31
P3829
P3885
mervyn-singer
P496
0000-0002-1042-6350
P569
1958-01-01T00:00:00Z
2000-01-01T00:00:00Z
P734
P735
P7859
lccn-n94803026